The present invention provides a modified cell having adhesion properties that are increased as compared to the adhesion properties of an unmodified cell, comprising a) a recombinant nucleic acid encoding an integrin β3 subunit; b) a recombinant nucleic acid encoding an integrin αv subunit; c) a recombinant nucleic acid encoding an integrin αIIb subunit; and/or d) any combination of (a), (b) and (c).